DelveInsight launched a new report on Presbyopia Market Insights, Epidemiology and Market Forecast 2030.
DelveInsight’s “Presbyopia Market Report 2030“ delivers an in-depth understanding of the Presbyopia , historical and forecasted epidemiology as well as the Presbyopia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Presbyopia is the normal loss of near focusing ability that occurs with age. Most people begin to notice the effects of presbyopia sometime after age 40. It is a result of a gradual decrease in accommodative amplitude, from about 15 diopters (D) to 1 D. This typically comes on between the ages of 40 and 60 as the lenses of the eyes naturally lose elasticity due to the ageing process.
View our detailed report: https://www.delveinsight.com/report-store/presbyopia-market
Presbyopia can be classified by type which includes:
1. Incipient presbyopia
2. Functional presbyopia
3. Absolute presbyopia
4. Premature presbyopia
5. Nocturnal presbyopia
Symptoms:
1. Delays in focusing at near or distance
2. Ocular discomfort
3. Headache
4. Asthenopia
5. Squinting
6 Fatigue
7. Need for brighter light for reading
8. Diplopia
Request for a detailed sample copy of the report: https://www.delveinsight.com/sample-request/presbyopia-market
“According to the research study of He et al. (2012), the prevalence rate of presbyopia was approximately 83% in the case of the United States.”
Market Insights:
There is a high unmet need for new therapies. There are currently no FDA-approved drugs for the treatment of presbyopia. Different approaches on the cornea and the crystalline lens are being pursued to achieve surgical correction of this disability. However, several limitations and considerations have prevented widespread acceptance of surgical correction for presbyopia. The quality of vision, optical and visual distortions, regression of effect, complications such as corneal ectasia and haze, anisometropia after monovision correction, impaired distance vision, and the invasive nature of the current techniques have limited the utilization of presbyopia surgery. Also, the standard-of-treatment is the use of reading glasses, which can be quickly misplaced, damaged, or broken. Glasses for reading must be regularly changed as presbyopia progresses.
Key companies:
1. Orasis Pharmaceuticals Ltd
2. Allergan
3. Novartis Pharmaceuticals
Click here and download a detailed sample copy of the report.
Table of contents
1 Key Insights 2 Executive Summary of Presbyopia 3 Presbyopia Market Overview at a Glance 4 Disease Background and Overview: Presbyopia 5 Case Reports 6 Presbyopia Epidemiology and Patient Population 7 United States Epidemiology 8 EU5 Epidemiology 9 Japan Epidemiology 10 Current Presbyopia Treatment and Medical Practices 11 Unmet needs 12 Presbyopia Marketed Drugs 13 Presbyopia Emerging Drugs 14 Presbyopia 7MM Market Analysis 15 United States 16 EU-5 countries: Market Outlook 17 Japan Market Outlook 18 Presbyopia Market Drivers 19 Presbyopia Market Barriers 20 SWOT Analysis 21 Reimbursement and market access 22 Appendix 23 DelveInsight Capabilities 24 Disclaimer 25 About DelveInsight
About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/